These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 15027455)

  • 1. The final sampling regulations of the Prescription Drug Marketing Act are alive and well: is your sampling program compliant?
    Romanski JA
    Food Drug Law J; 2003; 58(4):649-60. PubMed ID: 15027455
    [No Abstract]   [Full Text] [Related]  

  • 2. Not as easy as it may appear: using radio frequency identification technology to fulfill the Prescription Drug Marketing Act's elusive pedigree requirement.
    Asamoah AK
    Food Drug Law J; 2006; 61(2):385-418. PubMed ID: 16903035
    [No Abstract]   [Full Text] [Related]  

  • 3. Time and money: an analysis of the legislative efforts to address the prescription drug shortage crisis in America.
    Born K
    J Leg Med; 2012 Apr; 33(2):235-51. PubMed ID: 22694095
    [No Abstract]   [Full Text] [Related]  

  • 4. Foreign establishment registration and listing. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2001 Nov; 66(228):59138-61. PubMed ID: 11776289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; policies, requirements, and administrative procedures. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 1999 Dec; 64(232):67720-63. PubMed ID: 11010665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of certain drug products by registered blood establishments and comprehensive hemophilia diagnostic treatment centers that qualify as health care entities; Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; policies, requirements and administrative procedures. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2008 Oct; 73(197):59496-501. PubMed ID: 18985968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prescription drug marketing act: a solution in search of a problem?
    Angarola RT; Beach JE
    Food Drug Law J; 1996; 51(1):21-55. PubMed ID: 11794352
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmaceuticals: drug importation.
    Seay M; Jones TM
    Issue Brief Health Policy Track Serv; 2007 Jan; ():1-15. PubMed ID: 17361466
    [No Abstract]   [Full Text] [Related]  

  • 9. Seizures of Canadian drugs rise as Congress, Customs spar.
    Carreyrou J
    Wall St J (East Ed); 2006 Jul; ():B1, B8. PubMed ID: 16909501
    [No Abstract]   [Full Text] [Related]  

  • 10. The Prescription Drug Marketing Act of 1987.
    Greenberg RB
    Am J Hosp Pharm; 1988 Oct; 45(10):2118-26. PubMed ID: 3228083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmaceutical industry restructuring and new marketing approaches: enforcement responses.
    Mahinka SP; Sanzo KM
    Food Drug Law J; 1995; 50(2):313-25. PubMed ID: 10343000
    [No Abstract]   [Full Text] [Related]  

  • 12. Unlabeled drug samples and the learned intermediary: the case for drug company liability without preemption.
    Poser S
    Food Drug Law J; 2007; 62(4):653-94. PubMed ID: 18557225
    [No Abstract]   [Full Text] [Related]  

  • 13. Tobacco products, exemptions from substantial equivalence requirements. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2011 Jul; 76(128):38961-75. PubMed ID: 21735763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug marketing exclusivity under United States and European Union law.
    Junod V
    Food Drug Law J; 2004; 59(4):479-518. PubMed ID: 15875347
    [No Abstract]   [Full Text] [Related]  

  • 15. Prescription Drug Marketing Act Pedigree Requirements; effective date and compliance policy guide; request for comment. Final rule; announcement of effective date; notice of availability; request for comment.
    Food and Drug Administration, HHS
    Fed Regist; 2006 Jun; 71(114):34249-51. PubMed ID: 16795943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perception and process at the Food and Drug Administration: obligations and trade-offs in rules and guidances.
    Seiguer E; Smith JJ
    Food Drug Law J; 2005; 60(1):17-32. PubMed ID: 15940852
    [No Abstract]   [Full Text] [Related]  

  • 17. The World Health Organization's prequalification program and its potential effect on data exclusivity laws.
    Childs DW
    Food Drug Law J; 2005; 60(1):79-97. PubMed ID: 15940855
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmaceuticals and medical devices: business practices.
    ; Steiner DJ
    Issue Brief Health Policy Track Serv; 2014 Dec; ():1-38. PubMed ID: 25771555
    [No Abstract]   [Full Text] [Related]  

  • 19. Securing the US pharmaceutical supply.
    Somberg JC
    Am J Ther; 2008; 15(3):197. PubMed ID: 18496255
    [No Abstract]   [Full Text] [Related]  

  • 20. Remarks delivered at the Food and Drug Law Institute's 48th Annual Conference.
    Enzi MB
    Food Drug Law J; 2005; 60(2):103-6. PubMed ID: 16097090
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.